
Profitability, historical returns, and peer comparisons.
According to ANI Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 19.19%. This represents a change of 298.97% compared to the average of 4.81% of the last 4 quarters.
The mean historical ROE of ANI Pharmaceuticals, Inc. over the last ten years is -1.09%. The current 19.19% ROE has changed -1867.76% with respect to the historical average. Over the past ten years (40 quarters), ANIP's ROE was at its highest in in the March 2026 quarter at 5.24%. The ROE was at its lowest in in the June 2021 quarter at -7.35%.
Average
-1.09%
Median
0.85%
Minimum
-14.15%
Maximum
14.49%
Discovering the peaks and valleys of ANI Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 19.13%
Maximum Annual ROE = 14.49%
Minimum Annual Increase = -1375.67%
Minimum Annual ROE = -14.15%
| Year | ROE | Change |
|---|---|---|
| 2025 | 14.49% | -435.19% |
| 2024 | -4.32% | -205.32% |
| 2023 | 4.10% | -129.01% |
| 2022 | -14.15% | 19.13% |
| 2021 | -11.88% | 3.07% |
| 2020 | -11.52% | -502.32% |
| 2019 | 2.86% | -63.54% |
| 2018 | 7.85% | -1375.67% |
| 2017 | -0.62% | -126.55% |
| 2016 | 2.32% | -75.86% |
The current ROE of ANI Pharmaceuticals, Inc. (ANIP) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.76%
5-year avg
-2.35%
10-year avg
-1.09%
ANI Pharmaceuticals, Inc.’s ROE is less than Amphastar Pharmaceuticals, Inc. (10.11%), less than Bausch Health Companies Inc. (58.90%), less than Amneal Pharmaceuticals, Inc. (131.71%), greater than Viatris Inc. (-2.79%), less than Dr. Reddy's Laboratories Limited (7.37%), less than Teva Pharmaceutical Industries Limited (6.35%), greater than Harrow Health, Inc. (-103.86%), less than Collegium Pharmaceutical, Inc. (15.96%), less than Lifecore Biomedical, Inc. (1.38%), less than Evolus, Inc. (103.19%),
| Company | ROE | Market cap |
|---|---|---|
| 10.11% | $1.19B | |
| 58.90% | $3.12B | |
| 131.71% | $6.95B | |
| -2.79% | $22.08B | |
| 7.37% | $12.30B | |
| 6.35% | $48.77B | |
| -103.86% | $1.08B | |
| 15.96% | $770.59M | |
| 1.38% | $244.11M | |
| 103.19% | $493.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ANI Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ANI Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ANI Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for ANI Pharmaceuticals, Inc. (ANIP)?
What is the highest ROE for ANI Pharmaceuticals, Inc. (ANIP)?
What is the 3-year average ROE for ANI Pharmaceuticals, Inc. (ANIP)?
What is the 5-year average ROE for ANI Pharmaceuticals, Inc. (ANIP)?
How does the current ROE for ANI Pharmaceuticals, Inc. (ANIP) compare to its historical average?